Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 154 No. 10 (2024)

Patients with refractory musculoskeletal pain syndromes undergoing a multimodal assessment and therapy programme: a cross-sectional study

DOI
https://doi.org/10.57187/s.3466
Cite this as:
Swiss Med Wkly. 2024;154:3466
Published
21.10.2024

Summary

BACKGROUND: Chronic musculoskeletal pain syndromes, including fibromyalgia, are heterogeneous entities with a major socioeconomic burden. Multimodal treatment programmes have shown greater efficacy than conventional approaches for these patients, at least in the short term. A profound understanding of chronic musculoskeletal pain syndrome patients treated in multimodal treatment programmes is important for their development and to provide insight into these conditions.

AIM: To provide a comprehensive and objective description of medical, psychosocial and sleep characteristics of the treatment-refractory chronic musculoskeletal pain syndrome patients treated at the multimodal treatment programmes provided by our tertiary service in Switzerland.

METHODS: This was a cross-sectional analysis of 202 refractory chronic musculoskeletal pain syndrome patients with or without a concomitant autoimmune disorder hospitalised between 2018 and 2022 in a 12-day Swiss multimodal treatment programme. They underwent a comprehensive self-assessment with eight different questionnaires and assessments by a psychiatrist, rheumatologist, pain specialist, occupational therapist and physiotherapist. Sleep assessment was performed via actigraphy. Clinical and demographic variables were selected by consensus of three experienced rheumatologists and chronic pain specialists. The Fibromyalgia Rapid Screening Test (FiRST), American College of Rheumatology (ACR)-2010 criteria (ACR2010) and Toronto Alexithymia Scale-20 (TAS-20) were also applied.

RESULTS: The mean age of the patients was 47 years (SD = 10), 73% were female, and 30% were obese. Half (50%) were not from Switzerland, and 12% came from conflict zones. Almost half (40%) lived alone. Back pain was the principal site (90%). Of the patients, 78% fulfilled the ACR2010 criteria for fibromyalgia, and 17% were diagnosed with an underlying immune-mediated disorder, mostly spondylarthritis. Pain since childhood occurred in 45% of the patients, and 68% had pain since adolescence. Disability financial aid had been pursued by 69%, and 46% were still awaiting a response. Psychiatric comorbidities were highly prevalent (73%), of which 56% consisted of depression. Of all patients, 15% were diagnosed with enduring personality changes after a catastrophic experience (EPCACE), and 10% had post-traumatic stress disorder. Alexithymia affected 34% of patients. Objective sleep disorder was observed in 78% of patients, and 41% were under opioid therapy.

CONCLUSION: This analysis reveals the complex psychosomatic and socioeconomic patterns of the patients treated in Switzerland with refractory chronic musculoskeletal pain syndromes, often originating in childhood and adolescence. Obesity, immigration, social isolation, psychiatric comorbidities, sleep deprivation and opiate use, among others, stood out as target characteristics for further research.

References

  1. Stanaway, Jeffrey D et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global. Lancet. 2018 Nov 10;392(10159):1923-1994.
  2. St Sauver JL, Warner DO, Yawn BP, Jacobson DJ, McGree ME, Pankratz JJ, et al. Why patients visit their doctors: assessing the most prevalent conditions in a defined American population. Mayo Clin Proc. 2013 Jan;88(1):56–67. doi: https://doi.org/10.1016/j.mayocp.2012.08.020 DOI: https://doi.org/10.1016/j.mayocp.2012.08.020
  3. Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain. 2012 Aug;13(8):715–24. doi: https://doi.org/10.1016/j.jpain.2012.03.009 DOI: https://doi.org/10.1016/j.jpain.2012.03.009
  4. Schopflocher D, Taenzer P, Jovey R. The prevalence of chronic pain in Canada. Pain Res Manag. 2011;16(6):445–50. doi: https://doi.org/10.1155/2011/876306 DOI: https://doi.org/10.1155/2011/876306
  5. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006 May;10(4):287–333. doi: https://doi.org/10.1016/j.ejpain.2005.06.009 DOI: https://doi.org/10.1016/j.ejpain.2005.06.009
  6. Mansfield KE, Sim J, Jordan JL, Jordan KP, Bedson J, Pacey V. A systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population. Pain. 2020;161(9):2023–37.
  7. Carville SF, Arendt-Nielsen L, Bliddal H, Blotman F, Branco JC, Buskila D, et al.; EULAR. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008 Apr;67(4):536–41. doi: https://doi.org/10.1136/ard.2007.071522 DOI: https://doi.org/10.1136/ard.2007.071522
  8. Häuser W, Bernardy K, Arnold B, Offenbächer M, Schiltenwolf M. Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials. Arthritis Rheum. 2009 Feb;61(2):216–24. doi: https://doi.org/10.1002/art.24276 DOI: https://doi.org/10.1002/art.24276
  9. Kaiser U, Treede RD, Sabatowski R. Multimodal pain therapy in chronic noncancer pain-gold standard or need for further clarification? Pain. 2017 Oct;158(10):1853–9. doi: https://doi.org/10.1097/j.pain.0000000000000902 DOI: https://doi.org/10.1097/j.pain.0000000000000902
  10. Häuser W, Thieme K, Turk DC. Guidelines on the management of fibromyalgia syndrome - a systematic review. Eur J Pain. 2010 Jan;14(1):5–10. doi: https://doi.org/10.1016/j.ejpain.2009.01.006 DOI: https://doi.org/10.1016/j.ejpain.2009.01.006
  11. Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017 Feb;76(2):318–28. doi: https://doi.org/10.1136/annrheumdis-2016-209724 DOI: https://doi.org/10.1136/annrheumdis-2016-209724
  12. Nour Y, Abdelmoneem Y, Sameh G, Mohamed HE. Translation and validation of the Tampa Scale of Kinesiophobia Arabic version in chronic low back pain. Ann Phys Rehabil Med. 2017;60 S13:e20. doi: https://doi.org/10.1016/j.rehab.2017.07.145 DOI: https://doi.org/10.1016/j.rehab.2017.07.145
  13. French DJ, Noël M, Vigneau F, French JA, Cyr CP, Evans RT. PCS-CF: A French-language, French-Canadian adaptation of the Pain Catastrophizing Scale. Can J Behav Sci. 2005;37:181–92. doi: https://doi.org/10.1037/h0087255 DOI: https://doi.org/10.1037/h0087255
  14. Chaory, K., Fayad, F., Rannou, F., Lefèvre-Colau M. M., Fermanian, J., Revel, M., Poiraudeau, S. (2004). Validation of the French version of the fear avoidance belief questionnaire. Spine (Phila Pa 1976) 15;29(8), 908-13. doi: https://doi.org/10.1097/00007632-200404150-00018 DOI: https://doi.org/10.1097/00007632-200404150-00018
  15. Benaim, Charles, Léger, Bertrand, Vuistiner, Philippe, Luthi, François, Validation of the French Version of the “Patterns of Activity Measure” in Patients with Chronic Musculoskeletal Pain, Pain Research and Management, 2017, 6570394, 7 pages, 2017. DOI: https://doi.org/10.1155/2017/6570394
  16. Bocéréan C, Dupret E. A validation study of the Hospital Anxiety and Depression Scale (HADS) in a large sample of French employees. BMC Psychiatry. 2014 Dec;14(1):354. doi: https://doi.org/10.1186/s12888-014-0354-0 DOI: https://doi.org/10.1186/s12888-014-0354-0
  17. Poundja, J. B. A., Fikretoglu, D., Guay, F., Brunet, A. (2007 Validation of the French Version of the Brief Pain Inventory in Canadian Veterans Suffering from Traumatic Stress. Journal of Pain and Symptom Management, 33 (6), Issue 6, 720-726. doi: https://doi.org/10.1016/j.jpainsymman.2006.09.031 DOI: https://doi.org/10.1016/j.jpainsymman.2006.09.031
  18. Benz T, Lehmann S, Brioschi R, Elfering A, Aeschlimann A, Angst F. Comparison of short- and mid-term outcomes of Italian- and German-speaking patients after an interdisciplinary pain management programme in Switzerland: A prospective cohort study. J Rehabil Med. 2019 Feb;51(2):127–35. doi: https://doi.org/10.2340/16501977-2514 DOI: https://doi.org/10.2340/16501977-2514
  19. Osborne NR, Davis KD. Sex and gender differences in pain. In: Moro E, Arabia G, Tartaglia MC, Ferretti MT, editors. International Review of Neurobiology. Vol. 164. Academic Press; 2022. p. 277-307. doi: https://doi.org/10.1016/bs.irn.2022.06.013 DOI: https://doi.org/10.1016/bs.irn.2022.06.013
  20. Le couple [The couple] (2018). Swiss Federal Statistical Office. Available from https://www.bfs.admin.ch/bfs/fr/home/statistiques/population/familles/couple.html
  21. Berrut S, Mosimann A, Nicolet-dit-Félix M. (2018) Enquête sur les familles et les générations 2018 [Survey on families and generations 2018]. Swiss Federal Statistical Office. Available from https://www.bfs.admin.ch/bfs/fr/home/statistiques/population/enquetes/efg.assetdetail.10467789.html
  22. Souhait d'enfants, parentalité [desire for children, parenthood] (2018) Swiss Federal Statistical Office. Available from https://www.bfs.admin.ch/bfs/fr/home/statistiques/population/familles/souhait-enfants-parentalite.html
  23. Newton, B. J., Southall, J. L., Raphael, J. H., Ashford, R. L., & LeMarchand, K. (2013). A narrative review of the impact of disbelief in chronic pain. Pain management nursing: official journal of the American Society of Pain Management Nurses, 14(3), 161–171. doi: https://doi.org/10.1016/j.pmn.2010.09.001 DOI: https://doi.org/10.1016/j.pmn.2010.09.001
  24. Gonder ME, Orr WN, Khan TW. The Impact of Isolation During COVID-19 on Chronic Musculoskeletal Pain in the Geriatric Population: A Narrative Review. Pain Physician. 2022 Mar;25(2):E185–91.
  25. Oliveira VC, Ferreira ML, Morso L, Albert HB, Refshauge KM, Ferreira PH. Patients’ perceived level of social isolation affects the prognosis of low back pain. Eur J Pain. 2015 Apr;19(4):538–45. doi: https://doi.org/10.1002/ejp.578 DOI: https://doi.org/10.1002/ejp.578
  26. Galati M, Kaeser M, Semaani C, Storni M. (2017) Excès de poids et obésité. [Overweight and obesity]. Swiss Federal Statistical Office. Available from https://www.bfs.admin.ch/bfs/fr/home/statistiques/sante/determinants/exces-poids.html
  27. Santé des migrants [Migrants and health] (2019). Swiss Federal Statistical Office. Available from https://www.bfs.admin.ch/bfs/fr/home/statistiques/sante/etat-sante/migrants.html
  28. Okifuji A, Hare BD. The association between chronic pain and obesity. J Pain Res. 2015 Jul;8:399–408. doi: https://doi.org/10.2147/JPR.S55598 DOI: https://doi.org/10.2147/JPR.S55598
  29. Prego-Domínguez J, Khazaeipour Z, Mallah N, Takkouche B. Socioeconomic status and occurrence of chronic pain: a meta-analysis. Rheumatology (Oxford). 2021 Mar;60(3):1091–105. doi: https://doi.org/10.1093/rheumatology/keaa758 DOI: https://doi.org/10.1093/rheumatology/keaa758
  30. Häuser W, Galek A, Erbslöh-Möller B, Köllner V, Kühn-Becker H, Langhorst J, et al. Posttraumatic stress disorder in fibromyalgia syndrome: prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome. Pain. 2013 Aug;154(8):1216–23. doi: https://doi.org/10.1016/j.pain.2013.03.034 DOI: https://doi.org/10.1016/j.pain.2013.03.034
  31. Langvik E, Hjemdal O, Nordahl HM. Personality traits, gender differences and symptoms of anhedonia: what does the Hospital Anxiety and Depression Scale (HADS) measure in nonclinical settings? Scand J Psychol. 2016 Apr;57(2):144–51. doi: https://doi.org/10.1111/sjop.12272 DOI: https://doi.org/10.1111/sjop.12272
  32. Nortvedt MW, Riise T, Sanne B. Are men more depressed than women in Norway? Validity of the Hospital Anxiety and Depression Scale. J Psychosom Res. 2006 Feb;60(2):195–8. doi: https://doi.org/10.1016/j.jpsychores.2005.07.002 DOI: https://doi.org/10.1016/j.jpsychores.2005.07.002
  33. Aaron RV, Fisher EA, de la Vega R, Lumley MA, Palermo TM. Alexithymia in individuals with chronic pain and its relation to pain intensity, physical interference, depression, and anxiety: a systematic review and meta-analysis. Pain. 2019 May;160(5):994–1006. doi: https://doi.org/10.1097/j.pain.0000000000001487 DOI: https://doi.org/10.1097/j.pain.0000000000001487
  34. Palermo T. M. (2020). Pain prevention and management must begin in childhood: the key role of psychological interventions. Pain, 161 Suppl 1(Suppl), S114–S121. doi: https://doi.org/10.1097/j.pain.0000000000001862 DOI: https://doi.org/10.1097/j.pain.0000000000001862
  35. Groenewald CB, Law EF, Fisher E, Beals-Erickson SE, Palermo TM. Associations Between Adolescent Chronic Pain and Prescription Opioid Misuse in Adulthood. J Pain. 2019 Jan;20(1):28–37. doi: https://doi.org/10.1016/j.jpain.2018.07.007 DOI: https://doi.org/10.1016/j.jpain.2018.07.007
  36. Hatakeyama BA, Camargo BI, Santos VS, Leite MN, Espirito Santo CM, Kamper SJ, et al. Prevalence of disabling musculoskeletal pain in children and adolescents in Brazil: A cross-sectional study. Braz J Phys Ther. 2024;28(1):100593. doi: https://doi.org/10.1016/j.bjpt.2024.100593 DOI: https://doi.org/10.1016/j.bjpt.2024.100593
  37. Murray M, Stone A, Pearson V, Treisman G. Clinical solutions to chronic pain and the opiate epidemic. Prev Med. 2019 Jan;118:171–5. doi: https://doi.org/10.1016/j.ypmed.2018.10.004 DOI: https://doi.org/10.1016/j.ypmed.2018.10.004
  38. Chou R, Hartung D, Turner J, et al. (2020). Opioid Treatments for Chronic Pain [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); (Comparative Effectiveness Review, No. 229.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK556253/ DOI: https://doi.org/10.23970/AHRQEPCCER229
  39. Ju C, Wei L, Man KK, Wang Z, Ma TT, Chan AY, et al. Global, regional, and national trends in opioid analgesic consumption from 2015 to 2019: a longitudinal study. Lancet Public Health. 2022 Apr;7(4):e335–46. doi: https://doi.org/10.1016/S2468-2667(22)00013-5 DOI: https://doi.org/10.1016/S2468-2667(22)00013-5
  40. Bennett RM, Friend R, Marcus D, Bernstein C, Han BK, Yachoui R, et al. Criteria for the diagnosis of fibromyalgia: validation of the modified 2010 preliminary American College of Rheumatology criteria and the development of alternative criteria. Arthritis Care Res (Hoboken). 2014 Sep;66(9):1364–73. doi: https://doi.org/10.1002/acr.22301 DOI: https://doi.org/10.1002/acr.22301
  41. Fan A, Tournadre A, Pereira B, Tatar Z, Couderc M, Malochet-Guinamand S, et al. Performance of Fibromyalgia Rapid Screening Tool (FiRST) to detect fibromyalgia syndrome in rheumatic diseases. Rheumatology (Oxford). 2016 Oct;55(10):1746–50. doi: https://doi.org/10.1093/rheumatology/kew244 DOI: https://doi.org/10.1093/rheumatology/kew244
  42. Gilhus NE, Deuschl G. Neuroinflammation - a common thread in neurological disorders. Nat Rev Neurol. 2019 Aug;15(8):429–30. doi: https://doi.org/10.1038/s41582-019-0227-8 DOI: https://doi.org/10.1038/s41582-019-0227-8
  43. Sun Y, Laksono I, Selvanathan J, Saripella A, Nagappa M, Pham C, et al. Prevalence of sleep disturbances in patients with chronic non-cancer pain: A systematic review and meta-analysis. Sleep Med Rev. 2021 Jun;57:101467. doi: https://doi.org/10.1016/j.smrv.2021.101467 DOI: https://doi.org/10.1016/j.smrv.2021.101467
  44. Whale K, Gooberman-Hill R. The Importance of Sleep for People With Chronic Pain: Current Insights and Evidence. JBMR Plus. 2022a Jun;6(7):e10658. doi: https://doi.org/10.1002/jbm4.10658 DOI: https://doi.org/10.1002/jbm4.10658
  45. Whale K, Dennis J, Wylde V, Beswick A, Gooberman-Hill R. The effectiveness of non-pharmacological sleep interventions for people with chronic pain: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2022b May;23(1):440. doi: https://doi.org/10.1186/s12891-022-05318-5 DOI: https://doi.org/10.1186/s12891-022-05318-5